IQVIA Holdings, Inc.

American multinational company serving the combined industries of health information technology and clinical research

IQV NYSE ISIN US46266C1053 SEC CIK 1478242 LEI 549300W3R20NM4KQPH86
Follow Iqvia Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $4.4B +8% vs same quarter last year
Net income $350M +5.7% vs same quarter last year
EPS, diluted $2.10 +8.8% vs same quarter last year
Operating cash flow $825M −9.1% vs same quarter last year
Revenue by quarter
$4B
$3.8B
$4B
$4.1B
$4.4B
$4.2B
$4.4B
$4.4B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$16.3B$1.4B
FY24$15.4B$1.4B
FY23$15B$1.4B
FY22$14.4B$1.1B
FY21$13.9B$966M
FY20$11.4B$279M
FY19$11.1B$191M
FY18$10.4B$259M
FY17$9.7B$1.3B
FY16$6.8B$72M
FY15$5.7B$387M
FY14$5.5B$357M
FY13$5.1B$226.6M
FY12$4.9B$177.5M
FY11$4.3B$241.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-13.4%8.3%
FY24-14.3%8.9%
FY23-13.2%9.1%
FY22-12.5%7.6%
FY21-10%7%
FY20-6.4%2.5%
FY19-7%1.7%
FY18-7.1%2.5%
FY1752.4%6.9%13.2%
FY1652.5%8.5%1.1%
FY1552.8%11.3%6.7%
FY1451.2%10.8%6.5%
FY1351.5%9.1%4.4%
FY1249.5%8.1%3.6%
FY1150.3%8%5.6%
Free cash flowOperating cash flow minus capital expenditure
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$2.1B
FY24$2.1B
FY23$1.5B
FY22$1.6B
FY21$2.3B
FY20$1.3B
FY19$835M
FY18$795M
FY17$601M
FY16$696M
FY15$398M
FY14$350M
FY13$305M
FY12$264.4M
FY11$85.3M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25-$1.2B
FY24-$1.4B
FY23-$992M
FY22-$1.2B
FY21-$406M
FY20-$447M
FY19-$949M
FY18-$1.4B
FY17-$2.6B
FY16-$1.1B
FY15-$515M
FY14-$415M
FY13-$6.4M
FY12$567.9M$13.4M
FY11$288.3M$14.3M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Iqvia
  • Healthcare median
−100%−75%−50%−25%0%25%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearIqviaHealthcare median
FY258.3%−30.6%
FY248.9%−47%
FY239.1%−58%
FY227.6%−80.4%
FY217%−71.9%
FY202.5%−62.2%
FY191.7%−46.3%
FY182.5%−49.6%
FY1713.2%−45.9%
FY161.1%−36%
FY156.7%−38.4%
FY146.5%−35.5%
FY134.4%−37.1%
FY123.6%−29.1%
FY115.6%−27.9%